Skip to main content

Illinois IGB

Cancer

Researchers receive NCI grant to develop targeted cancer immunotherapies

September 23, 2022

Hua Wang (RBTE), a Materials Science and Engineering assistant professor, was recently awarded a 2.26M Research Project grant from the National Cancer Institute, which will support the development of type 1 conventional dendritic cells (cDC1) targeted cancer vaccines and cytokine therapies through the integration of immune cell homing materials and metabolic glycan labeling.


September 23, 2022


Related Articles

New therapeutic target identified for triple-negative breast cancer

August 26, 2022

Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple negative-breast cancer patients. In a new study, researchers have discovered that the nuclear receptor TLX can potentially be used for therapeutic intervention.


August 26, 2022


Related Articles

Ultra-sensitive biosensing technique can spot individual molecules that reveal cancer

August 22, 2022

Despite recent years’ dramatic improvements in cancer treatment, cancer remains second only to heart disease as a leading cause of death for Americans. But a new Nature Communications paper has reported exactly the kind of breakthrough that cancer patients yearn for: development of a highly sensitive new method for performing a liquid biopsy that can identify tiny numbers of individual cancer molecules.


August 22, 2022


Related Articles

Immunotherapy Trials Show Promise for Treating Canine Melanoma

August 9, 2022

Dr. Timothy Fan (ACPP), veterinary oncologist and professor at the University of Illinois College of Veterinary Medicine and a Program Leader for the Cancer Center at Illinois, is leading two clinical trials using similar immunotherapies to treat dogs with malignant melanoma. The novel approaches, developed in partnership with cancer researchers based in Boston, have yielded encouraging results in canine patients, and human trials using the same therapeutic platforms are expected to begin in 2023.


August 9, 2022


Related Articles

New engineering approach enhances antibody fragments for cancer therapy

April 21, 2022

Technological advancements over the past few decades have laid the groundwork for the use of microbe-based drugs to treat diseases. Bioengineering professor Shannon Sirk (MME) and her lab are engineering human commensal microbes into living therapeutics, delivering therapeutic proteins directly in the body, to make these drugs more accessible. 


April 21, 2022


Related Articles

Colorectal cancer in context: How food environment affects the gut

April 8, 2022

Colorectal cancer is expected to claim more than 52,000 American lives in 2022, and if this year is like most others, Black Americans will bear the brunt of the disease. To understand the disparity in context, University of Illinois researchers looked at the intersection of bile acids, gut microbes, racial identity, and neighborhood food environment in the development of colorectal cancer.


April 8, 2022


Related Articles

Acceleration of cancer biomarker detection for point of care diagnostics

January 27, 2022

The detection and quantification of cancer-associated molecular biomarkers in body fluids, or liquid biopsies, prove minimally invasive in early cancer diagnostics. Researchers at the University of Illinois Urbana-Champaign have developed an approach that accelerates the detection of cancer biomarkers in samples taken at the time and place of patient care.


January 27, 2022


Related Articles

Subscribe to Cancer